Ladenburg Thalmann Financial Services Inc. (NYSE MKT: LTS) today announced that David J. Strupp, Jr., a senior investment banker in the healthcare space, has joined Ladenburg Thalmann & Co. Inc. (“Ladenburg”) as a Managing Director, Healthcare Investment Banking, effective immediately. Mr. Strupp will be based in Ladenburg’s New York office. Mr. Strupp joins Ladenburg from Rodman & Renshaw, LLC, where he served as a Managing Director, Healthcare Investment Banking, and led efforts expanding the firm’s scope of financing transactions and broadening its client base. Mr. Strupp had served previously served as Partner and Head of Healthcare Investment Banking at ThinkEquity Partners, and a Director of the Global Healthcare Group, Investment Banking Division, at Salomon Smith Barney Inc. Mr. Strupp received a B.A. in Economics from Bates College, and a M.S. in Economics from the London School of Economics. Dr. Phillip Frost, Chairman of Ladenburg Thalmann Financial Services, said, “Ladenburg is pleased to add someone of David’s caliber to our already talented investment banking team, as we see substantial opportunity to continue to expand our efforts in the healthcare sector, a space we know well. In addition to Ladenburg’s growing investment banking and research capabilities, the firm has robust institutional distribution and a leading network of 2,700 independent financial advisors.” “We’re excited to welcome David to Ladenburg, as his depth and breadth of experience in the healthcare sector will be an invaluable asset to our Firm,” said David Rosenberg, Co-President and Chief Executive Officer of Ladenburg Thalmann & Co. Inc. “David has particular expertise advising life sciences, biotechnology, specialty pharmaceutical, medical technology and diagnostics companies, and we’re confident that he will make important contributions to Ladenburg’s future success.” Mr. Strupp said, “At a time when Ladenburg is extremely well-positioned for future growth in the space, I am thrilled to be joining the Firm and look forward to working with the talented team to expand its existing healthcare practice.”
About LadenburgLadenburg Thalmann Financial Services is engaged in independent brokerage and advisory services, investment banking, equity research, institutional sales and trading, and asset management services through its principal subsidiaries, Ladenburg Thalmann & Co. Inc., Investacorp, Inc., Triad Advisors, Inc. and Securities America, Inc., which together have approximately 2,700 financial advisors and approximately $70 billion in client assets. Founded in 1876 and a New York Stock Exchange member since 1879, Ladenburg Thalmann & Co. is a full service investment banking and brokerage firm providing services principally for middle market and emerging growth companies and high net worth individuals. Investacorp, Inc., a leading independent broker-dealer headquartered in Miami, Florida, has been serving the independent registered representative community since 1978. Founded in 1998, Triad Advisors, Inc. is a leading independent broker-dealer and registered investment advisor headquartered in Norcross, Georgia that offers a broad menu of products, services and total wealth management solutions. Securities America, based in Omaha, Nebraska, was founded in 1984 and is one of the largest and most successful independent broker-dealers in the country. Ladenburg Thalmann Financial Services is based in Miami, Florida. Ladenburg Thalmann & Co. is based in New York City, New York with regional offices in Miami and Boca Raton, Florida; Melville, New York; Boston, Massachusetts and Princeton, New Jersey. For more information, please visit www.ladenburg.com. This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future growth of Ladenburg's investment banking business, including its healthcare practice. These statements are based on management’s current expectations or beliefs and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of the Company’s business. These risks, uncertainties and contingencies include those set forth in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2011 and other factors detailed from time to time in its other filings with the Securities and Exchange Commission. The information set forth herein should be read in light of such risks. The Company is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.